Follow
Brian Conlon
Brian Conlon
Associate Professor, UNC Chapel Hill
Verified email at med.unc.edu
Title
Cited by
Cited by
Year
A new antibiotic kills pathogens without detectable resistance
LL Ling, T Schneider, AJ Peoples, AL Spoering, I Engels, BP Conlon, ...
Nature 517 (7535), 455-459, 2015
23422015
Activated ClpP kills persisters and eradicates a chronic biofilm infection
BP Conlon, ES Nakayasu, LE Fleck, MD LaFleur, VM Isabella, K Coleman, ...
Nature 503 (7476), 365-370, 2013
6242013
Persister formation in Staphylococcus aureus is associated with ATP depletion
BP Conlon, SE Rowe, AB Gandt, AS Nuxoll, NP Donegan, EA Zalis, ...
Nature microbiology 1 (5), 1-7, 2016
4252016
ATP-Dependent Persister Formation in Escherichia coli
Y Shan, A Brown Gandt, SE Rowe, JP Deisinger, BP Conlon, K Lewis
MBio 8 (1), e02267-16, 2017
2952017
Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus …
BP Conlon
Bioessays 36 (10), 991-996, 2014
1832014
Persister cells in biofilm associated infections
BP Conlon, SE Rowe, K Lewis
Biofilm-based healthcare-associated infections, 1-9, 2015
1492015
Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus
L Radlinski, SE Rowe, LB Kartchner, R Maile, BA Cairns, NP Vitko, ...
PLoS biology 15 (11), e2003981, 2017
1232017
Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells?
EM Waters, SE Rowe, JP O'Gara, BP Conlon
PLoS pathogens 12 (12), e1006012, 2016
1152016
Mutation of tagO reveals an essential role for wall teichoic acids in Staphylococcus epidermidis biofilm development
LM Holland, B Conlon, JP O'Gara
Microbiology 157 (2), 408-418, 2011
1012011
Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection
SE Rowe, NJ Wagner, L Li, JE Beam, AD Wilkinson, LC Radlinski, ...
Nature microbiology 5 (2), 282-290, 2020
962020
Dual targeting of cell wall precursors by teixobactin leads to cell lysis
T Homma, A Nuxoll, AB Gandt, P Ebner, I Engels, T Schneider, F Götz, ...
Antimicrobial agents and chemotherapy 60 (11), 6510-6517, 2016
852016
Stochastic variation in expression of the tricarboxylic acid cycle produces persister cells
EA Zalis, AS Nuxoll, S Manuse, G Clair, LC Radlinski, BP Conlon, ...
MBio 10 (5), e01930-19, 2019
692019
Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotype
BP Conlon, JA Geoghegan, EM Waters, H McCarthy, SE Rowe, ...
Journal of bacteriology 196 (24), 4268-4275, 2014
592014
Antibiotic efficacy in the complex infection environment
L Radlinski, BP Conlon
Current opinion in microbiology 42, 19-24, 2018
502018
Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus
LMG Bui, BP Conlon, SP Kidd
Essays in biochemistry 61 (1), 71-79, 2017
442017
ATP-dependent persister formation in Escherichia coli. mBio 8: e02267-16
Y Shan, A Brown Gandt, SE Rowe, JP Deisinger, BP Conlon, K Lewis
432017
Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in Staphylococcus aureus
LC Radlinski, SE Rowe, R Brzozowski, AD Wilkinson, R Huang, P Eswara, ...
Cell chemical biology 26 (10), 1355-1364. e4, 2019
402019
Equine or porcine synovial fluid as a novel ex vivo model for the study of bacterial free-floating biofilms that form in human joint infections
JM Gilbertie, LV Schnabel, NJ Hickok, ME Jacob, BP Conlon, IM Shapiro, ...
PLoS One 14 (8), e0221012, 2019
382019
Persisters: methods for isolation and identifying contributing factors—a review
SE Rowe, BP Conlon, I Keren, K Lewis
Bacterial persistence, 17-28, 2016
332016
Ureadepsipeptides as ClpP activators
EC Griffith, Y Zhao, AP Singh, BP Conlon, R Tangallapally, WR Shadrick, ...
ACS infectious diseases 5 (11), 1915-1925, 2019
162019
The system can't perform the operation now. Try again later.
Articles 1–20